Somite AI

Somite AI is a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development. They are building DeltaStem, a platform and foundation model designed to revolutionize the production of human cells, targeting key therapeutic programs such as those for type 1 diabetes and muscular diseases. Their proprietary capsule technology generates cell state transition data at unprecedented scale, driving the development of novel cell differentiation protocols.

Funding Round: Series A

Funding Amount: $47M

Date: 13-May-2025

Investors: Khosla Ventures, SciFi VC, the Chan Zuckerberg Initiative, Fusion Fund, Ajinomoto Group Ventures, Pitango HealthTech, TechAviv, Harpoon Ventures, Dr. R. Martin Chavez, Fidji Simo

Markets: TechBio, AI, Cell Therapy, Biotechnology, Artificial Intelligence (AI)

HQ: Boston, Massachusetts, United States

Founded: 2023

Website: https://somite.ai/

LinkedIn: https://www.linkedin.com/company/somite-therapeutics

Twitter: https://twitter.com/SomiteAi

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/somite

Pitchbook: https://pitchbook.com/profiles/company/541435-15